KALA
USDKALA BIO Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$0.740
Kõrge
$0.800
Madal
$0.740
Maht
0.08M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
5.3M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
1.11M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
HC Wainwright & Co. Maintains Buy on Kala Bio, Raises Price Target to $35
HC Wainwright & Co. analyst Yi Chen maintains Kala Bio with a Buy and raises the price target from $12 to $35.
Oppenheimer Maintains Outperform on Kala Bio, Raises Price Target to $33
Oppenheimer analyst Andreas Argyrides maintains Kala Bio with a Outperform and raises the price target from $15 to $33.
Mizuho Initiates Coverage On Kala Bio with Outperform Rating, Announces Price Target of $30
Mizuho analyst Graig Suvannavejh initiates coverage on Kala Bio with a Outperform rating and announces Price Target of $30.
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
ARLINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for
Seotud aktsiad
MNTX
Manitex International Inc.
MDWD
MediWound Ltd. Ordinary Shares
IDE
Voya Infrastructure Industrials and Materials Fund Common Shares of Beneficial Interest
ELAN
Elanco Animal Health Incorporated
ULH
Universal Logistics Holdings Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.